TSE:4204
TSE:4204Industrials

A Look At Sekisui Chemical (TSE:4204) Valuation After Mixed Earnings And Updated Full Year Outlook

Sekisui Chemical (TSE:4204) has just reported third quarter and nine month results, pairing slightly higher sales with lower net income, and backed this up with updated full year earnings guidance for investors to assess. See our latest analysis for Sekisui Chemical. The earnings update seems to have cooled sentiment slightly in the short term, with a 7 day share price return of 3.17% and a modest 1 month share price gain of 3.72%. At the same time, the 1 year total shareholder return of...
TSE:9533
TSE:9533Gas Utilities

A Look At Toho Gas (TSE:9533) Valuation As Board Weighs Stock Split And Shareholder Benefit Changes

Board meeting puts Toho Gas in focus Toho Gas (TSE:9533) is drawing attention after scheduling a January 30, 2026 board meeting to consider a stock split, amendments to its Articles of Incorporation, and changes to its shareholder benefit program. See our latest analysis for Toho Gas. Despite a 2.31% one day share price decline and a 3.55% seven day share price pullback to ¥5,115, Toho Gas still sits on a 9.69% 30 day and 11.22% 90 day share price return. Its 33.85% one year and very large...
TSE:6305
TSE:6305Machinery

A Look At Hitachi Construction Machinery (TSE:6305) Valuation After Raised Full Year Revenue And Profit Guidance

Raised guidance and regional demand drivers Hitachi Construction Machinery (TSE:6305) lifted its full year revenue and profit guidance after seeing stronger than expected replacement demand in Europe and Asia, ongoing infrastructure projects, and a resilient mining business. The company now forecasts full year revenue of ¥1,370,000 million, operating income of ¥137,000 million, and net income attributable to owners of the parent of ¥78,000 million, with projected earnings per share of...
TSE:9936
TSE:9936Hospitality

Ohsho Food Service (TSE:9936) Margin Holds Near 7% And Tests Cautious Growth Narratives

Ohsho Food Service (TSE:9936) has posted its Q3 2026 numbers with revenue of ¥28.8b and basic EPS of ¥29.57, while trailing twelve month EPS sits at ¥149.44 on revenue of ¥116.9b. The company has seen revenue move from ¥107.3b to ¥116.9b and trailing EPS climb from ¥132.57 to ¥149.44 over the last year, alongside 7.8% earnings growth and a net margin of 6.9% that is close to last year’s 7.0%. These results keep the focus firmly on how efficiently the business can hold its margins. See our...
TSE:4519
TSE:4519Pharmaceuticals

Stronger Q4 Results And Centennial Payout Could Be A Game Changer For Chugai Pharmaceutical (TSE:4519)

Chugai Pharmaceutical reported past fourth-quarter and full-year 2025 results showing higher sales of ¥283,200 million and revenue of ¥346,300 million in the quarter, alongside a planned ¥72 year-end dividend and a ¥75 special year-end dividend per share for approval at the March 2026 AGM. Alongside these payouts, Chugai reaffirmed its medium-term policy of targeting an average 45% dividend payout ratio versus Core EPS while planning to relocate its head office in 2029 to support its 2030...